Ingestible sensor-enabled Truvada®, taken as pre-exposure prophylaxis against HIV infection, identifies patterns of medication taking that may lead to risk of prophylactic failure in near real-time.
A new study reveals that ingestible sensor-enabled Truvada can identify patterns of medication taking behavior that may put individuals at risk of prophylactic failure. The system captures individual adherence patterns in real-time, allowing for tailored guidance and support.